{"status": "ok", "totalResults": 49, "articles": [{"source": {"id": "the-hindu", "name": "The Hindu"}, "author": "Special Correspondent", "title": "NORD plans to set up assembling plant in State", "description": "Markets in India have big scope: MD", "url": "https://www.thehindu.com/news/cities/Visakhapatnam/nord-plans-to-set-up-assembling-plant-in-state/article24897488.ece", "urlToImage": "https://www.thehindu.com/static/theme/default/base/img/og-image.jpg", "publishedAt": "2018-09-07T19:31:40Z", "content": "Mechanical and electrical solutions manufacturer NORD Drive Systems, a subsidiary of Germany-based Getriebebau NORD, organised an end-user service conference and a road show, in association with the AP Chambers of Commerce and Industry Federation (APCCIF) her\u2026 [+1092 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Lupin to train over 1,000 graduates for pharma industry by 2020", "description": "Lupin has launched its #39;Learn and Earn#39; initiative in which candidate who has passed Standard 12 in the science stream with a minimum of 50 percent marks but are facing financial constraints are taken for three-year-long course during which they are pai\u2026", "url": "https://www.moneycontrol.com/news/business/lupin-to-train-over-1000-graduates-for-pharma-industry-by-2020-2924881.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/07/Lupin-770x433.jpg", "publishedAt": "2018-09-06T10:46:05Z", "content": "Pharmceutical giant, Lupin Limited expects to train more than 1,000 under graduates into pharma professionals by the year 2020 under its Learn and Earn Initiative, a senior company official said today. Lupin has launched its 'Learn and Earn' initiative in whi\u2026 [+1850 chars]"}, {"source": {"id": null, "name": "Insightsonindia.com"}, "author": "InsightsIAS", "title": "Insights into Editorial: Biosimilars need huge investments, longer timelines", "description": "Insights into Editorial: Biosimilars need huge investments, longer timelines What are Biosimilars? A biosimilar is a biologic medical product that is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are \u2026", "url": "http://www.insightsonindia.com/2018/09/07/insights-into-editorial-biosimilars-need-huge-investments-longer-timelines/", "urlToImage": "http://www.insightsonindia.com/wp-content/uploads/2018/09/editorial-2.jpg", "publishedAt": "2018-09-07T03:41:45Z", "content": "Insights into Editorial: Biosimilars need huge investments, longer timelines What are Biosimilars? A biosimilar is a biologic medical product that is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are \u2026 [+5142 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Jimeet Modi", "title": "'Towards correction and selective profit taking'", "description": "Uncertainty is likely to persist and the downward drift might not ease anytime soon.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/journey-towards-correction-begins-its-time-for-selective-profit-taking/articleshow/65729453.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65729478,width-1070,height-580,imgsize-53614,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-08T05:33:34Z", "content": "Mr Market finally made a top during the week gone by and started correcting in response to the local and global tailwinds, primarily due to a strengthening dollar, growing current account deficit, inflationary expectations, global tightening and worsening geo\u2026 [+3224 chars]"}, {"source": {"id": null, "name": "Dailycaller.com"}, "author": "Mark Anthony", "title": "Drug Proposal Could Be Major Job Creator In India, China", "description": "Experts say American consumers may end up facing increased risks when buying medicines", "url": "https://dailycaller.com/2018/09/06/major-job-creator-in-india-china/", "urlToImage": "https://cdn01.dailycaller.com/wp-content/uploads/2018/09/1004465254-594x594-e1536261929709.jpg", "publishedAt": "2018-09-06T19:25:48Z", "content": "Drug companies in India and China are drooling over the prospect that many American jobs in the pharmaceutical industry could soon be outsourced overseas. The reason? A recent announcement from the U.S. Food and Drug Administration (FDA) that it is exploring \u2026 [+3702 chars]"}, {"source": {"id": null, "name": "Insightsonindia.com"}, "author": "InsightsIAS", "title": "SECURE SYNOPSIS: 04 SEPTEMBER 2018", "description": "SECURE SYNOPSIS: 04 SEPTEMBER 2018 NOTE: Please remember that following \u2018answers\u2019 are NOT \u2018model answers\u2019. They are NOT synopsis too if we go by definition of the term. What we are providing is content that both meets demand of the question and at the same ti\u2026", "url": "http://www.insightsonindia.com/2018/09/10/secure-synopsis-04-september-2018/", "urlToImage": "http://www.insightsonindia.com/wp-content/uploads/2018/09/6-2.jpg", "publishedAt": "2018-09-10T09:24:47Z", "content": "SECURE SYNOPSIS: 04 SEPTEMBER 2018 NOTE: Please remember that following \u2018answers\u2019 are NOT \u2018model answers\u2019. They are NOT synopsis too if we go by definition of the term. What we are providing is content that both meets demand of the question and at the same ti\u2026 [+49807 chars]"}, {"source": {"id": null, "name": "Prnewswire.com"}, "author": null, "title": "E-Clinical Trials Market Growth Driven by Rising R&D Spending by Pharma-Biotech Companies for Innovative Drug Development: Radiant Insights, Inc.", "description": "SAN FRANCISCO, September 11, 2018 /PRNewswire/ -- Global E-clinical Trials Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. E-clinical Trials is termed as a trial \u2026", "url": "https://www.prnewswire.com/news-releases/e-clinical-trials-market-growth-driven-by-rising-r-amp-d-spending-by-pharma-biotech-companies-for-innovative-drug-development-radiant-insights-inc--871693114.html", "urlToImage": "/content/dam/prnewswire/common/prn_facebook_sharing_logo.jpg", "publishedAt": "2018-09-11T09:45:00Z", "content": "SAN FRANCISCO, September 11, 2018 /PRNewswire/ -- Global E-clinical Trials Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. E-clinical Trials is termed as a trial \u2026 [+5126 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Rob Merrick, Rob Merrick", "title": "UK taxpayers to foot bill for stockpiling medicines to prepare for no-deal Brexit", "description": "'We are talking to the pharmaceutical industry about the extra cost that they might have to incur,' Matt Hancock says", "url": "https://www.independent.co.uk/news/uk/politics/no-deal-brexit-medicine-stockpile-taxpayers-nhs-matt-hancock-a8525051.html", "urlToImage": "https://static.independent.co.uk/s3fs-public/thumbnails/image/2017/11/15/13/medicines.png", "publishedAt": "2018-09-06T08:11:42Z", "content": "Taxpayers will have to foot the bill for stockpiling NHS medicines to prepare for crashing out of the EU without a deal, the health secretary says. Matt Hancock revealed he was \u201ctalking to pharmaceutical industry about what extra costs the government should c\u2026 [+9743 chars]"}, {"source": {"id": null, "name": "Thehindubusinessline.com"}, "author": "Rajiv Nath", "title": "Profit-making device", "description": "No level-playing field in medical devices market", "url": "https://www.thehindubusinessline.com/opinion/columns/profit-making-device/article24884323.ece", "urlToImage": "https://www.thehindubusinessline.com/opinion/columns/4ppz1h/article24884321.ece/ALTERNATES/LANDSCAPE_615/BL07THINKMED1", "publishedAt": "2018-09-06T15:37:07Z", "content": "Rajiv Nath The Global Healthcare Access and Quality Index (2018) ranks India at 145 among 190 nations, lower than Bangladesh, Sudan and Equatorial Guinea. This ranking should drive the authorities and industry to change this landscape by ensuring affordable a\u2026 [+3231 chars]"}, {"source": {"id": null, "name": "Seekingalpha.com"}, "author": "SA Transcripts", "title": "Lakeland Industries, Inc. (LAKE) CEO Christopher Ryan on Q2 2019 Results - Earnings Call Transcript", "description": "Lakeland Industries, Inc. (NASDAQ:LAKE) Q2 2019 Earnings Conference Call September 10, 2018 04:30 PM ET Executives Christopher Ryan - Chief Executive Officer Te", "url": "https://seekingalpha.com/article/4205429-lakeland-industries-inc-lake-ceo-christopher-ryan-q2-2019-results-earnings-call-transcript", "urlToImage": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "publishedAt": "2018-09-11T00:16:05Z", "content": "Lakeland Industries, Inc. (NASDAQ: LAKE ) Q2 2019 Earnings Conference Call September 10, 2018 4:30 PM ET Executives Christopher Ryan - Chief Executive Officer Teri Hunt - Chief Financial Officer Analysts Dave King - ROTH Capital Alex Fuhrman - Craig-Hallum Ca\u2026 [+29460 chars]"}, {"source": {"id": null, "name": "Thehindubusinessline.com"}, "author": "Shobha Roy", "title": "NetMeds to set up brick-and-mortar pharmacies", "description": "Shobha RoyOnline pharmacy marketplace NetMeds is looking to set up offline stores to cater to tier II, III and IV markets. According to Pradeep Dadha", "url": "https://www.thehindubusinessline.com/companies/netmeds-to-set-up-brick-and-mortar-pharmacies/article24908170.ece", "urlToImage": "https://www.thehindubusinessline.com/companies/9vxssk/article24908169.ece/ALTERNATES/LANDSCAPE_615/Mr%20Pradeep%20Dadha%20Founder%20and%20CEO%20Netmedscom", "publishedAt": "2018-09-09T11:17:43Z", "content": "Shobha Roy Online pharmacy marketplace NetMeds is looking to set up offline stores to cater to tier II, III and IV markets. According to Pradeep Dadha, founder and CEO, a pilot project is under way to \u2018understand and evaluate\u2019 the offline model. \u201cIn three mon\u2026 [+1862 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ETMarkets.com", "title": "BSE, PTC India, Bharat Forge, SpiceJet and Tata Motors among stocks in the news", "description": "Here's a look at the top stocks that may hog the limelight in today's session:", "url": "https://economictimes.indiatimes.com/markets/stocks/news/bse-ptc-india-bharat-forge-spicejet-and-tata-motors-among-stocks-in-the-news/articleshow/65762532.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65762590,width-1070,height-580,imgsize-145376,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-11T02:48:49Z", "content": "NEW DELHI: Nifty futures on the Singapore Exchange were trading 7 points, or 0.06 per cent, lower at 11,479.50, indicating a flat start for the Nifty50. Here's a look at the top stocks that may hog the limelight in today's session: BSE, PTC India : Leading st\u2026 [+2726 chars]"}, {"source": {"id": null, "name": "Business-standard.com"}, "author": "SI Reporter", "title": "This pharma stock zooms over 100% in five weeks", "description": "The stock hit a new high of Rs 830, up 10% in the intraday trade today, rallied 103% from Rs 408 on August 7, as compared to 0.58% rise in the S&P BSE Sensex.", "url": "https://www.business-standard.com/article/markets/this-pharma-stock-zooms-over-100-in-5-weeks-118091100250_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2017-10/27/full/1509051031-9738.jpg", "publishedAt": "2018-09-11T06:20:00Z", "content": "Shares of Albert David hit a new high of Rs 830, up 10%, surging more than 100% in past five weeks in otherwise weak market. The stock of pharmaceutical company zoomed 103% from Rs 408 on August 7, as compared to 0.58% rise in the S&amp;P BSE Sensex. Albert D\u2026 [+1912 chars]"}, {"source": {"id": null, "name": "Triplepundit.com"}, "author": "Tina Casey", "title": "How Sustainable Hydrogen Could Help Solve the Ocean Plastic Problem", "description": "In an interesting environmental two-fer, a new process could recycle plastic waste -- including ocean plastic -- into sustainable hydrogen for fuel cells. The post How Sustainable Hydrogen Could Help Solve the Ocean Plastic Problem appeared first on Triple Pu\u2026", "url": "http://www.triplepundit.com/2018/09/how-sustainable-hydrogen-could-help-solve-the-ocean-plastic-problem/", "urlToImage": "https://cdn.triplepundit.com/wp-content/uploads/2018/09/recycled-plastic-sustainable-hydrogen.png", "publishedAt": "2018-09-11T09:10:50Z", "content": "The quest for the sustainable hydrogen economy of the future is getting more complicated by the minute, as more evidence emerges about the role of natural gas in global warming. What\u2019s the connection? Well, hydrogen is an abundant, zero emission fuel. The pro\u2026 [+4963 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "PTI", "title": "Lupin to train over 1,000 graduates for pharma industry", "description": "Mumbai-headquartered Lupin has estimated that by the year 2020 they would be spending almost Rs 20 crore on this programme.", "url": "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-to-train-over-1000-graduates-for-pharma-industry/articleshow/65705126.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65705685,width-1070,height-580,imgsize-37954,overlay-economictimes/photo.jpg", "publishedAt": "2018-09-06T11:05:16Z", "content": "Pharmceutical giant, Lupin Limited expects to train more than 1,000 under graduates into pharma professionals by the year 2020 under its Learn and Earn Initiative, a senior company official said today. Lupin has launched its 'Learn and Earn' initiative in whi\u2026 [+1852 chars]"}, {"source": {"id": null, "name": "Prnewswire.com"}, "author": null, "title": "Commercial Seaweed Market Size Worth $22.13 Billion by 2024: Grand View Research, Inc.", "description": "SAN FRANCISCO, September 10, 2018 /PRNewswire/ -- The global commercial seaweed market size is anticipated to reach USD 22.13 billion by 2024, according to a new report by Grand View Research, Inc. The global market is estimated to witness a healthy CAGR of 8\u2026", "url": "https://www.prnewswire.com/news-releases/commercial-seaweed-market-size-worth-22-13-billion-by-2024-grand-view-research-inc--869527118.html", "urlToImage": "https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg?p=facebook", "publishedAt": "2018-09-10T10:25:00Z", "content": "SAN FRANCISCO, September 10, 2018 /PRNewswire/ -- The global commercial seaweed market size is anticipated to reach USD 22.13 billion by 2024, according to a new report by Grand View Research, Inc. The global market is estimated to witness a healthy CAGR of 8\u2026 [+4301 chars]"}, {"source": {"id": null, "name": "Livemint.com"}, "author": "George Smith Alexander, Bloomberg", "title": "Once-in-a-lifetime deal-making spree underway in India", "description": "M&A deals involving Indian companies have reached $104.5 billion in 2018, trouncing the previous annual record with almost four months left in the year", "url": "https://www.livemint.com/Companies/BM0Hdgp8E5mRlgxXKqFxJM/Onceinalifetime-dealmaking-spree-underway-in-India.html", "urlToImage": "https://www.livemint.com/rf/Image-621x414/LiveMint/Period2/2018/09/11/Photos/Processed/Flipkart-walmart-kxrB--621x414@LiveMint.jpg", "publishedAt": "2018-09-10T06:33:38Z", "content": "Mumbai: The biggest mergers and acquisitions (M&amp;A) boom in Indian history has investment bankers preparing for even more deal-making to come. Transactions involving Indian companies have reached $104.5 billion in 2018, trouncing the previous annual record\u2026 [+3553 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Nifty to consolidate amid IIP, WPI data; top 3 stocks to bet on", "description": "Sumit Bilgaiyan of Equity99 expects the Nifty to consolidate between last week\u00e2\u0080\u0099s high-low levels", "url": "https://www.moneycontrol.com/news/business/markets/nifty-to-consolidate-amid-iip-wpi-data-top-3-stocks-to-bet-on-2932061.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/08/Sensex_Nifty_BSE_Stock-Market_traders-770x433.jpg", "publishedAt": "2018-09-09T03:04:37Z", "content": "Sumit Bilgaiyan Equity99 On a weekly basis, profit booking was seen in the market last week after six consecutive weeks. Along with the Nifty, the Bank Nifty, Midcap and Smallcap indices have also seen strong selling pressure during the first half of the week\u2026 [+4611 chars]"}, {"source": {"id": null, "name": "Ndtv.com"}, "author": null, "title": "Deals Worth $100 Billion In India's Biggest Merger And Acquisition Boom", "description": "Transactions involving domestic companies have reached $104.5 billion in 2018, trouncing the previous annual record with almost four months left in the year, according to data compiled by Bloomberg.", "url": "https://www.ndtv.com/business/deals-worth-100-billion-in-indias-biggest-merger-and-acquisition-boom-1914107", "urlToImage": "https://c.ndtvimg.com/2018-09/tqo48lps_bloomberg-train_625x300_10_September_18.jpg", "publishedAt": "2018-09-10T07:31:51Z", "content": "A sustained dealmaking boom, however, is far from guaranteed. The biggest mergers-and-acquisitions boom in Indian history has investment bankers preparing for even more dealmaking to come. Transactions involving domestic companies have reached $104.5 billion \u2026 [+3746 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Bloomberg", "title": "Once-in-a-lifetime deals fuel a $100 billion India M&A boom", "description": "A combination of various factors has created an unprecedented opportunity for dealmaking in India.", "url": "https://economictimes.indiatimes.com/news/company/corporate-trends/once-in-a-lifetime-deals-fuel-a-100-billion-india-ma-boom/articleshow/65749055.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65749100,width-1070,height-580,imgsize-82661,overlay-economictimes/photo.jpg", "publishedAt": "2018-09-10T04:37:04Z", "content": "by George Smith Alexander The biggest mergers-and-acquisitions boom in Indian history has investment bankers preparing for even more dealmaking to come. Transactions involving Indian companies have reached $104.5 billion in 2018, trouncing the previous annual\u2026 [+3576 chars]"}]}